fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Scientists reveal mechanism that causes irritable bowel syndrome

Written by | 7 May 2021

KU Leuven researchers have identified the biological mechanism that explains why some people experience abdominal pain when they eat certain foods. The finding paves the way for more… read more.

Gut microbes may antagonize or assist in anorexia

Written by | 23 Jan 2021

You are likely familiar with the serious consequences of anorexia for those who experience it, but you might not be aware that the disorder may not be purely… read more.

Poor gut health connected to severe COVID-19

Written by | 22 Jan 2021

People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems.

Nanoplastics alter intestinal microbiome and threaten human health

Written by | 11 Jan 2021

We live in a world invaded by plastic. Its role as a chemically stable, versatile and multi-purpose fostered its massive use, which has finally translated into our current… read more.

Testing for hepatitis C virus remains low among baby boomers

Written by | 17 Nov 2019

Two years after recommendations, only a small percentage have been tested. A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus… read more.

IBD: the perfect example of translational medicine?

Written by | 12 Nov 2019

The genetic and clinical heterogeneity of IBD means translational research has a key role to play. A session dedicated to translational and basic science at UEG Week 2019… read more.

IBD healthcare and patient-reported outcomes

Written by | 12 Nov 2019

An oral abstract session dedicated to patient-reported outcomes (PROs) in IBD included surveys from France and the Netherlands and from the multi-centre ICONIC study.. Written by Maria Dalby

Disease monitoring in IBD – implementation in practice

Written by | 12 Nov 2019

Dr Maria Abreu (Miami, USA) gives us an overview of implementing disease monitoring and its challenges in clinical practice  Written by Maria Dalby

Late-breaking abstracts: IBD highlights

Written by | 12 Nov 2019

A subcutaneous formulation of infliximab, known as CT-P13 SC, has been developed with a view to offer greater flexibility and convenience for patients. 

Randomised controlled trials session

Written by | 12 Nov 2019

In a round-up of randomised controlled studies in IBD at UEG Week 2019 included results from the maintenance phase of the UNIFI study in UC and a phase-3… read more.

Updates from VARSITY: histologic remission

Written by | 12 Nov 2019

Professor Jean-Frédéric Colombel (Icahn School of Medicine at Mount Sinai, New York, USA) opened the symposium with an overview of how treatment targets in UC have evolved from improving… read more.

Highlights from UEGW 2019

Written by | 12 Nov 2019

UEGW 2019, held in Barcelona, Spain, was a very interesting meeting, covering a wide range of hot topics from the world on IBD. The meeting was well-attended with… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.